29.90
-0.17%
Close of 9 Nov 2026, in TWD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Taiyen Biotech Co
Its shares trade on Taiwan Stock Exchange under the ticker 1737.TW. It has been listed since 18 November 2003. In the fiscal year to 31 December 2025, it reported revenue of TWD 3.31bn and net income of TWD 399.9m. At that date it held total assets of TWD 8.26bn and shareholders' equity of TWD 6.81bn.
Taiyen Biotech Co., Ltd. is engaged in the manufacture, research and development of salt, beauty care, bottled water, cleaning and health food products. The company is headquartered in Tainan, Tainan. The company went IPO on 2003-11-18. The firm offers salt products, skin care and cosmetics, bottled water products, facial and body cleansers, health and dietary supplements, as well as other products, such as collagen raw materials, biomedical materials, microbial agents and others. The Company’s salt products include fine salts, dried salts, low sodium salts, bay salts and other salts, which are applied in industry, agriculture, food processing, cooking and others. The firm distributes its products in Taiwan market and to overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Food Products
- Listed since
- 18 Nov 2003
- Website
- tybio.com.tw ↗
Leadership
Pay as last reported
- Mr. Yanzhe DingChairman of the Board, since 2024
- Mr. Chieh-Han LiDeputy General Manager, Corporate Governance Officer
- Ms. Wei SuHead of Finance & Accounting
- Mr. Kuo-Hsiang ChaoDirector
- Mr. Kuan-Ping ChenDirector
- Mr. Wei-Yi ChuLabor Director
- Mr. Hsien-Kuei LiaoDirector
- Ms. Chia-Ling LiIndependent Director
- Mr. Yu-Pen LinIndependent Director
- Mr. Shih-Hao WuIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Taiyen Biotech Co Ltd possesses several key strengths that contribute to its competitiveness in the market. Firstly, the company has a strong reputation for high-quality biotech products, which increases customer trust and loyalty. Additionally, Taiyen Biotech Co Ltd has an experienced and knowledgeable team of experts who possess cutting-edge expertise in the field. This allows the company to stay at the forefront of innovation and deliver impactful solutions to customers. Lastly, Taiyen Biotech Co Ltd benefits from strategic collaborations and partnerships with renowned research institutions, providing valuable resources and opportunities for growth.
Weaknesses
- Despite its strengths, Taiyen Biotech Co Ltd also faces several weaknesses that need to be addressed. Firstly, the company's heavy reliance on a limited number of key customers poses a risk to its revenue stability. Diversifying the customer base should be a priority for mitigating this vulnerability. Additionally, Taiyen Biotech Co Ltd may face challenges in terms of scalability due to its relatively small size and limited resources. Investing in infrastructure and operational expansion should be considered to ensure sustained growth.
Opportunities
- Taiyen Biotech Co Ltd operates in an industry with immense growth potential. The increasing demand for biotech solutions across various sectors, such as agriculture, pharmaceuticals, and healthcare, presents significant opportunities for the company to expand its market share. Moreover, the rise of personalized medicine and advancements in genetic engineering open up avenues for Taiyen Biotech Co Ltd to develop innovative products and services that cater to emerging customer needs. Exploring strategic partnerships and collaborations with academic institutions and industry leaders can further enhance the company's growth prospects.
Threats
- Taiyen Biotech Co Ltd faces certain threats that may impact its operations and market position. One major threat is increasing competition within the biotech industry. The presence of established players and the emergence of new startups intensify the competition for market share and talent, requiring Taiyen Biotech Co Ltd to continuously innovate and differentiate itself. Additionally, regulatory changes and compliance requirements in the biotech sector pose challenges and necessitate staying up-to-date with evolving regulations. Economic fluctuations and global uncertainties may also impact customer demand and investment in biotech solutions, which can threaten the company's financial stability.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.